01.11.2013 | consensus report | Ausgabe 21-22/2013 Open Access

Management of dabigatran-induced bleeding: expert statement
- Zeitschrift:
- Wiener klinische Wochenschrift > Ausgabe 21-22/2013
Wichtige Hinweise
Electronic supplementary material
The online version of this article (doi: 10.1007/s00508-013-0430-3) contains supplementary material, which is available to authorized users.
Summary
The interdisciplinary group of experts has compiled a clinical guidance for manifest dabigatran-induced haemorrhage and envisaged invasive interventions on patients under dabigatran. It recommends an escalation of treatment measures as summarized in a pocket guide (see electronic supplementary material online and insert in the print issue).